Perhaps in the progression of CHB disease, HBV reduces the risk of atherosclerosis through the incompletely verified molecular mechanism, resulting in a negative correlation between ApoB/ApoA1 ratio and the prevalence of HCC and LC. The gene discussed is APOB; the disease is laryngotracheoesophageal cleft.